Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema

Table 2

Descriptive angioedema incident data. Some patients had experienced angioedema in more than one location; thus, the numbers does not add up to 100.

Parameter
Localization of angioedema, , (%)
(i) Head and neck		100 (95.2%)
(ii) Peripheral		14 (13.3%)
(iii) Abdominal		3 (2.9%)
Concomitant rash, , (%)		19 (18%)
Treatment of acute attacks, , (%)
Antihistamines	96 (91.4%)	Efficacy reported by 62.5%
Corticosteroids	79 (75.2%)	Efficacy reported by 63.3%
Adrenaline	20 (19.0%)	Efficacy reported by 15.0%
Icatibant	3 (2.9%)	Efficacy reported by 66.7%
Tranexamic acid	1 (<1%)	Efficacy reported by 0%
Beta-2 agonists	1 (<1%)	Unknown effect
Montelukast	2 (1.9%)	Unknown effect
Azathioprine	1 (<1%)	Unknown effect
Airway management
Intubation	4 patients	3.8%
Tracheostomy	1 patient	0.9%